相关实验视频
Updated: Jun 18, 2025

04:44
Developing a Rat Model for Bipolar Disorder
Published on: May 2, 2025
234
[双极情绪障碍与精神药物治疗诱导的躁狂阶段发生]
A S Shteinberg1, A N Barkhatova1, A S Berezkin1
1Mental Health Research Centre, Moscow, Russia.
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
|July 29, 2024
概括
抗抑郁药可以触发躁狂阶段在双相情感障碍患者,需要谨慎的治疗策略. 研究正在发展,以个性化双相情感障碍护理,并尽量减少有害的副作用.
科学领域:
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
- 神经科学是一个神经科学.
背景情况:
- 自20世纪以来,人们已经认识到抗抑郁药引起的躁狂症在双相情感障碍中的风险.
- 在双相抑郁症中使用抗抑郁药可以导致诸如情绪转换和加速循环等不良影响.
研究的目的:
- 分析关于双相情感障碍中药物治疗诱导的躁狂阶段的历史发展和当前研究趋势.
- 探索对双相情感障碍的诊断和治疗的不断变化的观点,重点是尽量减少催产素效应.
主要方法:
- 通过使用关键词进行了全面的文献搜索,例如"药物诱导的躁狂"和"双相情感障碍".
- 出版物来源于PubMed/MEDLINE,俄罗斯引用索引和其他数据库,从19世纪中叶到现在.
主要成果:
- 历史观察强调抗抑郁药的风险导致情绪逆转和恶化双相患者的疾病过程.
- 最近的研究整合了临床,药理动力学,遗传学和神经生理学数据,以了解这些现象.
结论:
- 了解双极性障碍治疗的演变对于管理心理药物治疗诱导的躁狂阶段至关重要.
- 生物精神病学的进步为双相情感障碍的个性化医疗方法铺平了道路,旨在减少催产素并发症.
相关概念视频
Mania and Antimanic Drugs: Overview
157
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
157
Bipolar Disorder
61
Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
61
Psychosis: Goals of Pharmacotherapy
114
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
114
Psychosis and Antipsychotic Drugs: Overview
214
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
214
Drug Therapy
41
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
41
Antidepressant Drugs: MAOIs and Other Agents
209
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
209

